Although paediatric data are limited, early studies suggest that terlipressin may also be effective in children, potentially stabilizing renal function and serving as a bridge to transplantation.

AUSTIN, Texas -- Hepatorenal syndrome (HRS) type 1 patients showed clinically meaningful responses to terlipressin (Terlivaz) under an alternative definition of treatment success, according to a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. CHARLOTTE, N.C. — A subgroup analysis of liver ...

– HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with ...

Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...

Credit: Getty Images. Terlivaz is a vasopressin analogue selective for V1 receptors. The Food and Drug Administration (FDA) has approved Terlivaz ® (terlipressin) injection to improve kidney function ...

Credit: Getty Images. The Company is currently evaluating OCE-205 in a phase 2 trial in adults who have developed hepatorenal syndrome with acute kidney injury. The Food and Drug Administration (FDA) ...

– Pooled analysis from Phase 3 clinical trials highlights liver transplant rates in adult patients with HRS with rapid reduction in kidney function treated with TERLIVAZ1 – TERLIVAZ is the first and ...

The FDA approved terlipressin (Terlivaz), the first drug for treating patients with hepatorenal syndrome (HRS). A synthetic vasopressin analog, terlipressin is an injectable drug indicated for ...

DUBLIN, Oct. 30, 2025 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced the presentation of two posters on terlipressin in patients with hepatorenal syndrome ...

The US Food and Drug Administration (FDA) has approved terlipressin (Terlivaz), the first and only drug approved for patients with hepatorenal syndrome (HRS). HRS is characterized by progressive ...

DENVER, Oct. 18, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation ...